2.16.840.1.113883.1.11.19787/static-2012-07-24: Unterschied zwischen den Versionen
ADbot (Diskussion | Beiträge) (Automated TermBot page content) |
ADbot (Diskussion | Beiträge) (Automated TermBot page content) |
||
Zeile 9: | Zeile 9: | ||
| colspan=2 bgcolor="#F6F3EE"|''SupplyOrderAbortReasonCode'' | | colspan=2 bgcolor="#F6F3EE"|''SupplyOrderAbortReasonCode'' | ||
| bgcolor="#F6F3EE"|2.16.840.1.113883.1.11.19787 | | bgcolor="#F6F3EE"|2.16.840.1.113883.1.11.19787 | ||
− | | bgcolor="#F6F3EE"|2012-07- | + | | bgcolor="#F6F3EE"|2012-07-24 |
| bgcolor="#F6F3EE"|definitiv | | bgcolor="#F6F3EE"|definitiv | ||
+ | |- | ||
+ | | colspan=5 | Quell-Kodesystem(e): | ||
+ | * [[2.16.840.1.113883.5.8]] (ActReason) | ||
|- | |- | ||
! bgcolor="#ECE9E4" align="left"|'''Level/Typ''' | ! bgcolor="#ECE9E4" align="left"|'''Level/Typ''' | ||
Zeile 21: | Zeile 24: | ||
|_SupplyOrderAbortReasonCode | |_SupplyOrderAbortReasonCode | ||
|supply order abort reason | |supply order abort reason | ||
− | | | + | |ActReason |
|- | |- | ||
|1-L | |1-L | ||
|'''IMPROV''' | |'''IMPROV''' | ||
|condition improved | |condition improved | ||
− | | | + | |ActReason |
|- | |- | ||
|1-L | |1-L | ||
|'''INTOL''' | |'''INTOL''' | ||
|intolerance | |intolerance | ||
− | | | + | |ActReason |
|- | |- | ||
|1-L | |1-L | ||
|'''NEWSTR''' | |'''NEWSTR''' | ||
|new strength | |new strength | ||
− | | | + | |ActReason |
|- | |- | ||
|1-L | |1-L | ||
|'''NEWTHER''' | |'''NEWTHER''' | ||
|new therapy | |new therapy | ||
− | | | + | |ActReason |
|} | |} |
Aktuelle Version vom 11. November 2012, 18:38 Uhr
Value Set Name | Value Set Id | Version / Eingangsdatum | Status | |
---|---|---|---|---|
SupplyOrderAbortReasonCode | 2.16.840.1.113883.1.11.19787 | 2012-07-24 | definitiv | |
Quell-Kodesystem(e):
| ||||
Level/Typ | Code | Anzeigename | Kodesystem | |
0-A | _SupplyOrderAbortReasonCode | supply order abort reason | ActReason | |
1-L | IMPROV | condition improved | ActReason | |
1-L | INTOL | intolerance | ActReason | |
1-L | NEWSTR | new strength | ActReason | |
1-L | NEWTHER | new therapy | ActReason |